University of Patras
Προς την κλινική ενσωμάτωση της φαρμακογονιδιωματικης: οικονομική αξιολόγηση των φαρμακογονιδιωματικών ελέγχων και συμπεριφορικοί παράγοντες υιοθέτησής τους από τους ιατρούς
Abstract
dc:descriptionThis PhD thesis addresses the clinical integration of Pharmacogenomics (PGx) through a holistic and multidimensional approach, by investigating the phenomenon from different spectrum simultaneously. PGx is approached as a combination of economic, organizational, and behavioral challenge. Despite the fact that there is an exponential growth of genomic and PGx data along with the well-documented clinical utility of drug-gene interactions, the rate of PGx integration into healthcare systems remains low due to technical, economic, institutional, and socio-behavioral barriers. The purpose of this dissertation is to bridge this gap by demonstrating the cost-effectiveness of PGx testing and providing an in-depth study of the behavioral factors that affect physicians' intentions to adopt it into daily clinical practice, utilizing a cross-national methodological triangulation. In the first phase, a cost-effectiveness analysis of PGx-guided antiplatelet therapy with clopidogrel based on the CYP2C19 genotype was conducted, utilizing raw clinical and economic data from 243 patients with Acute Coronary Syndrome (ACS) from the Spanish cohort of the pan-European PREPARE study. The results demonstrated that the PGx-guided strategy constitutes a dominant, cost-saving option, as it reduced total healthcare costs by half (€883 versus €1755 per patient). This difference is attributed to a statistically significant reduction in hospitalisation days and visits to the emergency department, as well as a total decrease in adverse events. The probabilistic sensitivity analysis confirmed the robustness of the model, showing that the probability of the PGx approach being cost-effective exceeds 71% at lower willingness-to-pay thresholds. In the second phase, a qualitative methodology was adopted through semi-structured interviews with Greek physicians of various specialties, based on the Consolidated Framework for Implementation Research (CFIR 2.0), in order to map systemic barriers in Greece. Although clinical physicians recognize the theoretical value of the method, a profound "knowledge gap" and low clinical readiness were revealed, stemming from the absence of relevant university education. The main barriers cited were the lack of reimbursement from insurance funds, the absence of national guidelines, the lack of digital Clinical Decision Support (CDS) systems, and concerns regarding the management of sensitive genetic data. In the third phase, a nationwide quantitative study was conducted with a sample of 337 physicians using structural equation modeling (SEM) based on the modified Unified Theory of Acceptance and Use of Technology model (UTAUT). The statistical analysis quantified the mechanisms of adoption, proving that performance expectancy and perceived usefulness positively influence prescribing intention; however, their impact is significantly constrained by inadequate facilitating conditions within the healthcare system. Furthermore, the introduction of the professional and legal liability variable highlighted the absence of a unified legal framework to dictate the distinction of roles and responsibilities among stakeholders. These facts seem to intensify physician hesitation towards PGx adoption. In conclusion, this PhD thesis synthesizes the findings of the individual studies, demonstrating that economic efficiency is a necessary but not sufficient condition for clinical integration. The work culminates in a comprehensive health policy proposal for the Greek system, underlining the need to institutionalize preemptive reimbursement, integrate digital CDS tools into electronic prescribing, and reshape medical education so that Pharmacogenomics can be transformed from a laboratory innovation into an accessible and safe strategy to promote personalised medicine into public health.
Degree
thesis:*- Grantor dc:publisher
- University of Patras
- Year dc:date
- 2026
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Koufaki, Margarita-Ioanna
- Κουφάκη, Μαργαρίτα-Ιωάννα
Subjects
dc:subject × 24- Οικονομικά της υγείας
- Οικονομική αξιολόγηση
- Φαρμακογονιδιωματική
- Φαρμακευτικό μάρκετινγκ
- Προθέσεις συμπεριφοράς
- Ιατροί
- Συμπεριφορική Θεωρία
- Ενοποιημένη θεωρία αποδοχής και χρήσης της τεχνολογίας
- Στρατηγική επικοινωνίας
- Health economics
- Economic evaluation
- Pharmacogenomics
- Pharmaceutical marketing
- Behavioural intentions
- Physicians
- Behavioral theory
- Unified theory of acceptance and use of technology
- Communication strategy
- Οικονομικά και Επιχειρήσεις
- Κοινωνικές Επιστήμες
- Οικονομικά
- Economics and Business
- Social Sciences
- Ecomonics
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/62403